EUVIMEDEUVIMED entdecken
Crossref

Clinical, epidemiological, and diagnostic aspects of erythroplasia of queyrat

Valeriy V. Dubenskiy, Ekaterina S. Muraveva, Vladislav V. Dubensky

Russian Journal of Skin and Venereal Diseases · 06.04.2026 · 29 (2) · 127-137

DOI: 10.17816/dv699575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Russian Journal of Skin and Venereal Diseases, online erschienen am 06.04.2026. Verfasst von Valeriy V. Dubenskiy und 2 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Erythroplasia of Queyrat (ICD-10 code: D07.4) is an intraepithelial neoplasia affecting the glans penis and inner preputial leaf. It is classified as a squamous cell carcinoma in situ. However, available publications lack data on its prevalence across age groups. AIM: The work aimed to examine the clinical and epidemiological aspects of erythroplasia of Queyrat and assess the efficacy of various diagnostic approaches. METHODS: A retrospective, cross-sectional case history study in patients who sought medical advice for penile lesions of various origins (n = 327) and a prospective observational study in patients with erythroplasia of Queyrat (n = 49) were conducted. Toluidine blue staining, dermatoscopy, and cytological and histological examinations were used in the diagnosis of erythroplasia of Queyrat. Additionally, an ultrasound of the penis and inguinal lymph nodes, tests for sexually transmitted infections, and a transrectal prostate ultrasound were performed. RESULTS: The observational study in patients with erythroplasia of Queyrat revealed a trend towards younger onset. The majority of patients (30.61%) were aged 50–59 years, with the disease detected before the age of 29 in 12.24% of cases and at the age of 30–39 in 20.4% of cases. A total of 89.8% of patients saw physicians of various specialties (urologists, dermatovenerologists, oncologists, etc.), whereas 10.2% self-medicated. The time between the onset of penile rashes and seeking medical advice is particularly concerning, ranging from 1 week (4.0%) to more than 5 years (2.0%). Thus, patients with a disease duration of ≥ 1 year (12.1%) are at the highest risk of penile squamous cell carcinoma. The majority of patients with erythroplasia of Queyrat consult with a dermatovenerologist, with the final diagnosis made on the initial or follow-up visit in 93.87% of cases, indicating that dermatovenerologists are familiar with clinical signs and diagnostic approaches in this condition. CONCLUSION: This work addresses the gaps in the modern assessment of clinical and epidemiological aspects and diagnostic efficacy in patients with erythroplasia of Queyrat, facilitating the selection of effective therapeutic options.

Zitieren

APA

Dubenskiy, V. V., Muraveva, E. S., & Dubensky, V. V. (2026). Clinical, epidemiological, and diagnostic aspects of erythroplasia of queyrat. Russian Journal of Skin and Venereal Diseases, 29(2), 127-137. https://doi.org/10.17816/dv699575

Vancouver

Dubenskiy VV, Muraveva ES, Dubensky VV. Clinical, epidemiological, and diagnostic aspects of erythroplasia of queyrat. Russian Journal of Skin and Venereal Diseases. 2026;29(2):127-137. doi:10.17816/dv699575

BibTeX
@article{Dubenskiy2026,
  author = {Dubenskiy, Valeriy V. and Muraveva, Ekaterina S. and Dubensky, Vladislav V.},
  title = {Clinical, epidemiological, and diagnostic aspects of erythroplasia of queyrat},
  journal = {Russian Journal of Skin and Venereal Diseases},
  year = {2026},
  volume = {29},
  number = {2},
  pages = {127--137},
  doi = {10.17816/dv699575}
}
Kostenlos starten →